Comment on "Effectiveness of a Group B outer membrane vesicle meningococcal vaccine in preventing hospitalization from gonorrhea in New Zealand: a retrospective cohort study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005".
Chris Richard KenyonPublished in: Vaccines (2019)
Available evidence suggests MeNZB™ is not associated with a durable effect against N. gonorrhoeae.